Peritoneal therapeutic fluid comprising one or more of a biocompatibility enhancing agent (BCA) that is selected from the group consisting of a polyphenolic compound a metabolite of a polyphenolic compound which is obtained by metabolization in the human or animal body a salt or a glycoside of a polyphenolic compound.